{{Rsnum
|rsid=251177
|Gene=FCHSD1
|Chromosome=5
|position=141647317
|Orientation=plus
|GMAF=0.2025
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=FCHSD1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.4 | 36.3 | 59.3
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 15.6 | 50.3 | 34.0
| ASW | 14.0 | 52.6 | 33.3
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 25.7 | 74.3
| LWK | 18.2 | 55.5 | 26.4
| MEX | 0.0 | 25.9 | 74.1
| MKK | 28.2 | 51.3 | 20.5
| TSI | 17.6 | 31.4 | 51.0
| HapMapRevision=28
}}
[[rs251177]] is one of seven SNPs found in a combined study of over 1,000 patients to be associated with increased risk for [[prostate cancer]]. The risk allele for this SNP is (C); and while the odds ratio was not specifically reported, the probability of false significance (not permuted though) was given as p=0.000188, using an additive model of risk.{{PMID|18073375}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}